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The past decade has seen a growth in demand for human eggs for stem cell related research and, more
recently, for mitochondrial research. That demand has been accompanied by global debates over
whether women should be encouraged, by offers of payments, in cash or kind, to provide eggs. Few of
these debates have been informed by empirical evidence, let alone by the views of women themselves.
This article addresses that gap in knowledge by presenting ﬁndings from a UK investigation, conducted
2008e2011, which is the ﬁrst systematic study of women volunteering to provide eggs under such cir-
cumstances. This article focuses on the views and experiences of 25 IVF patients who volunteered for the
Newcastle ‘egg sharing for research’ scheme (NESR), in exchange for reduced IVF fees. This was an
interview based study, designed to gain understandings of volunteers’ perspectives and reasoning. The
interviews show that volunteers approached the scheme as a way of accessing more treatment in pursuit
of their goal of having a baby, against a landscape of inadequate state provision of treatment and
expensive private treatment. The process of deciding to volunteer raised a wide range of uncertainties
about the consequent gains and losses, for women already in the uncertain world of the ‘IVF roll-
ercoaster’. However, interviewees preferred to have the option of the NESR, than not, and they juggled
the numerous uncertainties with skill and resilience. The article is as revealing of the ongoing challenges
of the UK IVF bio-economy as it is of egg provision. This article adds to the growing body of knowledge of
the contributions of tissue providers to the global bio-economy. It also contributes to several areas of
wider sociological interest, including debates on the social management of ‘uncertainty’ and discussions
at the interface of sociology and ethics.
 2013 Elsevier Ltd. Open access under CC BY license.Introduction and background
In 2001 the UK became the ﬁrst country to permit the use of
human eggs in somatic cell nuclear transfer (SCNT or ‘therapeutic
cloning’) research, followed by China, Japan, Singapore, South Ko-
rea (Mayor, 2004) then Australia, Sweden, Spain, Israel and India
(Waldby, 2008:20); in the USA it continues mostly through private
funding (Roxland, 2012). Research into mitochondrial disease has
created further demand for human eggs (Human Fertilisation and
Embryology Authority (HFEA), 2011; Nufﬁeld Council on Bioethics
(NCoB), 2012). Eggs are provided either by women undergoing
in vitro fertilisation (IVF) or women in the general population; IVF
patients can provide either ‘failed-to-fertilise’ eggs (which are no
use for their treatment) or ‘fresh’ eggs collected before fertilisation
has been attempted (whose potential to assist their treatment has
therefore not been tested).7741.
ense.Numerous debates have arisen over the social and ethical
challenges involved in acquiring eggs for research (Haimes, Taylor,
& Turkmendag, 2012; Waldby & Carroll, 2012), highlighted by the
‘Hwang scandal’ which revealed falsiﬁed results and the likely
abuse of women persuaded to provide eggs (Baylis, 2009). One
contentious issue is whether women should be given any ﬁnancial,
or other, return, either for the eggs, or for undergoing the possible
risks of ovarian stimulation and egg collection (Egli et al., 2011).
The European Society of Human Reproduction and Embryology
endorsed payments to egg providers, arguing that compensation to
IVF providers should be moremodest than for non-IVF providers as
IVF patients undergo interventions as part of their treatment any-
way (Pennings et al., 2007:1210). However, the idea of payments
has attracted criticism around the world: are they undue in-
ducements compromising women’s autonomy and ability to give
informed consent; are they exploitative of poorer women; are they
payments for eggs, thereby contributing to the commodiﬁcation of
human body parts (Roxland, 2012)? Some feminists called for a
moratorium on egg extraction for research (Plows, 2011:52e3),
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Roberts and Throsby (2008:160) suggest a moratorium fails ‘to
address the complexity of women’s relationship to reproductive
technology and biomedicine’.
Few of these debates are informed by empirical evidence (Braun
& Schultz, 2012), let alone by research that investigates the per-
spectives of women volunteering to provide eggs (Klitzman &
Sauer, 2009). Our study addresses that gap in knowledge by
investigating the views and experiences of IVF patients volunteer-
ing for the UK-based ‘Newcastle egg sharing for research’ scheme
(NESR). In this scheme, ran by the Newcastle Fertility Centre (NFC)
and established to provide eggs for nuclear transfer research, pa-
tients were given a reduction of £1500 in the fees for one IVF cycle
when they agreed to provide 50% of their fresh eggs from that cycle.
Full fees were approximately £3,000e£3700 per cycle (NFC, 2012).
The NESR has a controversial history. It arose from collaboration
between the NFC and the Northeast England Stem Cell Institute,
whose scientists argued that better SCNT results would be achieved
if they could use fresh eggs rather than potentially faulty, ‘failed-to-
fertilise’ eggs (Stojkovic et al., 2005). The scheme initially received
only a provisional licence from the HFEA, subject to the outcomes of
a public consultation (HFEA, 2006). It received full approval in 2007,
an ‘incoherent’ decision according to Braun and Schultz (2012:15)
because it contradicted existing HFEA policies of non-payment for
gametes and embryos; the HFEA responded that since they allowed
‘egg sharing for the treatment of other couples’ (EST), which gives
heavily subsidized fees to the egg provider, ‘egg sharing for
research’ (ESR) should also be allowed. Roberts and Throsby (2008)
commented that NESR egg providers were being ‘paid to share’; the
Singapore Bioethics Advisory Committee expressed ‘serious con-
cerns’ that the NESR was exploitative (SBAC, 2008: 4.23).
However, the U.K. Medical Research Council (MRC) funded the
nuclear transfer research (NT), including the discount to egg pro-
viders. They also funded our independent investigation of volun-
teers’ experiences. Our central research question was ‘does egg
sharing for NT research, in exchange for reduced IVF fees, entail
social and ethical costs for those coming forward to participate in
the scheme?’ This was a deliberately broad question, designed to
maximise the opportunities to understand the scheme from the
perspectives of the women themselves. It was thought that these
perspectives would include, but also go beyond, views about
payment. As the ﬁrst empirical investigation of the perspectives of
IVF patients volunteering to provide eggs under such terms, this
studymakes several contributions: it establishes the importance of
understanding such schemes from the perspectives of women
volunteering; it raises questions for egg acquisition schemes
worldwide; it opens up ‘bioethics’ debates to social science
investigation and analysis (Haimes & Williams, 2007); it adds to
the growing body of knowledge of the contribution of tissue pro-
viders to the global bio-economy (Almeling, 2011; Waldby and
Cooper, 2010).
At the time of our study the terms of the NESR were: (i) women
had to volunteer as potential egg providers, in response to media
coverage or clinic information leaﬂets; clinicians could not ask
them directly for eggs; (ii) women should have had IVF previously,
to conﬁrm it was needed, and be aged 21e35; (iii) the consenting
process should be conducted by an independent research nurse;
(iv) if women produced six or more fresh eggs, they kept 50% and
researchers received 50%, allocated one-by-one, on retrieval; if
women produced an odd number of eggs they retained the extra
one; if women produced ﬁve or fewer eggs they kept them all and
still received the discount; women could choose their own, higher,
threshold of eggs before the agreement was triggered; (v) women
could change their minds up to egg retrieval but had to pay the full
fees.We have addressed the question of ‘exploitation’ and the NESR
elsewhere (Haimes et al., 2012). In this paper I present a wider
range of data, to provide contextualised ‘speciﬁcities’ (Roberts &
Throsby, 2008:160) of how the NESR is experienced, and shaped,
by women volunteers. This complements Roberts & Throsby’s
(2008:160) insightful, text-based, analysis of the ‘discursive con-
struction’ of the NESR with the volunteers’ lived experiences. The
data presented here focus on how the IVF interviewees approached
the decision to volunteer in the ﬁrst place. They show that women
situated their decision within a complex array of uncertainties
about the gains and losses associated with giving up fresh eggs
while receiving a discount, in the contexts of the already uncertain
world of IVF (Ehrich, Williams, Farsides, & Scott, 2012) and of the
UK IVF bio-economy. These insights help to answer Roberts and
Throsby’s (2008:160) question ‘as to why anyone undergoing
fertility treatment would donate eggs potentially useful for their
own treatment’ and illuminate the normative debates about pay-
ment, inducement and commodiﬁcation in egg provision.
Methodology
This was an interview based, inductive study, designed to gain
understandings of the perspectives and reasoning of NESR volun-
teers. ‘Volunteer’ refers to women and couples who came forward
as potential egg providers; ‘provision’ is used to avoid the more
contestable discourses of ‘sharing’, ‘donating’ or ‘gifting’ (Almeling,
2011). Our project was approved by the local research ethics
committee in 2008. The author is employed at the same university
as that towhich those running the NESR are afﬁliated; however, our
project, though conducted with the full co-operation of the NFC, is
completely independent. A Project Advisory Group (PAG) ensured
analytical objectivity was maintained. Members included a senior
scientist with a public record of opposing the NESR and SCNT
research using human eggs and senior colleagues from Sociology,
Law and Philosophy from other universities; they advised on study
design, interviewee recruitment, data collection, analysis, and
dissemination.
Fieldwork was conducted from 2008 to 2011. Since one of our
goalswas to understandwhether volunteering created any social and
ethical costs,weapproached allwomenwhohadvolunteered for the
NESR. This included women who had gone on to provide eggs,
women who had been accepted for the scheme but withdrew, and
women who were not accepted, since we wanted to know the rea-
sons for withdrawing and the effects of not being accepted. Volun-
teers were contacted by letter and information leaﬂet, sent on our
behalf by the NFC, requesting participation in an interview. Those
who agreed returned a signed consent form to us. Thus, we had no
contact with patients unless, and until, they agreed to participate in
our study and the NFC did not know which patients agreed to help
us. Volunteers who had had recent IVF were contacted at least six
weeks after their pregnancy test results. A total of 246 letters were
sent, resulting in 25 interviews with IVF patients who had vol-
unteered for the NESR. Seven of the 25 had been accepted for the
NESR and had provided eggs; three were accepted but had with-
drawn; 15 did not progress beyond the early stages, some of whom
had been deemed unsuitable. While 25 in-depth interviews pro-
vided more than sufﬁcient data to reach thematic saturation and to
provide rich insights into the volunteering experience, further
comparisons between the experiences of providing eggs, with-
drawing, and being rejected, could have been made if more in-
terviews within these sub-categories had been possible.
Nonetheless, the data presented below focus on issues that had to be
considered by all IVF volunteers, whether or not they provided eggs.
The author conducted all the interviews, enabling ongoing
analysis and progressive focussing. The aide-memoir covered:
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of the NESR; views on broader debates on providing and acquiring
eggs for research, and reﬂections on their volunteering experiences.
However, the interviewees shaped the discussions, introducing
topics and terminology relevant to their experiences. Most in-
terviews lasted 60e90 min; all were fully transcribed. Transcripts
were checked, anonymised and de-identiﬁed by the Research As-
sistant; the author and the RA then independently identiﬁed lists of
major themes which were systematically compared and reﬁned;
initial coding of randomly selected transcripts led to further
reﬁnement of major themes; an agreed list of 19 themes was then
used by the author to code all the transcripts. Constant comparison
and category-building procedures, followed by category mapping
(Silverman, 2001) were used to sort data extracts. These analytical
strategies and procedures were discussed with the PAG. As part of
our wider study, we also conducted 42 interviews with other
groups for a range of comparative purposes but I focus here on the
accounts of the 25 IVF volunteers.
Volunteers’ views and experiences
I shall outline interviewees’ views and experiences of volun-
teering for the NESR under three headings: (1) their experiences of
fertility problems and treatment; (2) the issues they considered
when deciding to volunteer; (3) their overall evaluations of the
NESR.
The infertility and IVF rollercoaster
All interviewees echoed, throughout their interviews, the now
well-documented (Spar, 2006:1e30) difﬁculties of infertility and of
IVF treatment (Aarts et al., 2012). Given that these stresses are
widely acknowledged I shall keep this material brief, in order to
retain space for newer insights from our study. Nevertheless, it is
important to hear some examples of interviewees’ graphic de-
scriptions. One described the ‘mental toll’ of infertility; ‘it really
impacted my life badly’ (M06:1020e68 and 860e914). Another said,
‘it’s a rollercoaster every month’ (M25:6806). Interviewees described
IVF as ‘horrendous, physically, emotionally, ﬁnancially’ (M11:980e
1012) and as ‘a hard experience, very, very emotional. a real roll-
ercoaster’ (M19:1279e91). The ﬁrst cycle of IVF was the most difﬁ-
cult; at least in later cycles, ‘I knew what to expect’ (M24:428e528).
IVF success rates remain low: the 2009 HFEA ﬁgures (the most
recent available) show that forwomen aged under 35 years, 32.3% of
IVF treatments using fresh eggs resulted in a live birth (HFEA, 2012a).
Nonetheless, these interviewees were seeking further treatment. In
light of the descriptions above this suggests that IVF itself can be a
combination of loss, gain and uncertainty: it is horrendous to go
through, but if it results in a baby, it is probablyworth it (Thompson,
2005). It is this desire for a baby that emerged as the volunteers’
central, sense-making, frame, as they explained their approach to
the NESR.
Losing eggs, gaining the discount, juggling uncertainties
In deciding whether to volunteer, interviewees had toweigh the
prospect of reducing their fresh eggs by 50% against the value of the
discount. Central to their accounts was uncertainty about what they
were gaining and losing especially as their handling of these two
elements was embedded within a range of other, entangled,
uncertainties.
Losing eggs?
Since fresh eggs (in contrast to failed-to-fertilise eggs) ‘are al-
ways potentially useful to patients’ (Roberts & Throsby, 2008:160;Waldby & Carroll, 2012) and since patients regard producing sufﬁ-
cient eggs as an early successful step in IVF (Haimes & Taylor, 2009),
it is unsurprising that, for most interviewees, contemplating losing
50%of those eggswas a signiﬁcant consideration.Most interviewees
(including all seven who went on to provide eggs) reported having
produced ‘lots’ of eggs in previous cycles, ranging from 17 to 46:
‘. it’s not something that somebody who wasn’t producing a lot.
could really think about, because it’s halving their chances’
(M02:469e510).
Previous experience also alerted interviewees to the variability
in these numbers: one woman who had produced ‘lots’ previously,
only had three in hermost recent cycle: ‘Now I know that if I was to do
it again I probablywouldn’t have asmany as I thought’ (M09:772e85).
Interviewees also knew from previous IVF the complex rela-
tionship between numbers of eggs, numbers of viable embryos and
the likelihood of a baby (termed elsewhere ‘the calculus of
conception’ (Haimes & Taylor, 2009:2143)). One said, ‘we tried to do
it statistically’, using numbers from a previous cycle to decide the
minimum number of eggs to keep before triggering the NESR
arrangement (M10:372e409). Another calculated:
‘. the more eggs you have, the more chance they give us, so [giving
some up] was a big worry. So even though we had a lot of eggs,
19,.maybe only 10 [fertilised].I’d half my chances again if we
[only] had half the eggs I’d made’ (M11:687e702)
Another said, ‘you never know. anything under [ten] I was keen
to keep. You always think on the day “oh howmany are we going
to have? How many are going to fertilise?”’ (M05:582e657).
Contemplating reducing their eggs by 50% was made easier by
the terms of the NESR: ‘[It] was reassuring to know that if you did
have a small amount you weren’t going to lose half’ (M03:551e98).
They could also withdraw but at a cost: ‘You can always change
your mind if you’re bordering on seven, eight and you don’t want to
risk it. But you do have to pay the full amount!’ (M07:394e442).
Interviewees expressed little interest in changing the policy on
the number of eggs a woman should have before the agreement
was triggered; they simply wanted ‘enough’ to feel conﬁdent that
providing 50% to research would not damage their chances of
pregnancy. Therefore, from the outset of considering volunteering,
women had to work with uncertainties about the number of eggs
they would have and the effect of reducing that number by 50%.
They combined previous IVF experiences with the terms of the
NESR to try to judge the risks of volunteering.
Gaining the discount?
Overwhelmingly, interviewees’ perspectives on the reduced
fees were tied to concerns about (a) the costs of private treatment
and (b) levels of state-funded IVF in the UK. Once the possibility of
IVF had arisen, interviewees had immediately started thinking
about how to manage the potential costs. They were confronted by
the entanglement of treatment, babies and money long before they
heard about the NESR: ‘money is the thing with IVF, unfortunately,
that’s what it boils down to’ (M21:344e57).
(a) Private fees: The costs of private treatment were raised by
almost all interviewees: ‘a hell of a lot’ even half price (M16: 943e
62); ‘really, really expensive’ (M28:255e311). One couple suggested
clinics have ‘captive audiences’ so can charge what they want
(M01:957). There was worrying uncertainty about how high fees
would eventually be since, when they embark on treatment, pa-
tients cannot be sure how many procedures, drugs or cycles they
will need. For most interviewees, the NESR offered the chance of a
cycle that otherwise would not have been affordable or reassurance
that they would be able to afford treatment more easily. The
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would not have been able to do another cycle then if we didn’t have the
assistance of the egg sharing scheme.’ (M03:600e56). One woman
said she could ‘afford’ more treatment by using credit cards: ‘I
would just have been more in debt [laughing] and I wouldn’t have
probably been able to have it as frequently’ (M07:557e618). Another
said, ‘.ﬁnancially [IVF] nearly ruined us the ﬁrst time. this really
would have been probably our last go, ﬁnancially and emotionally. But
we didn’t have the money for a full treatment.’ (M06:943e77).
Interestingly, there was little relationship between in-
terviewees’ sense of the affordability of any/further IVF and their
incomes. Interviewees reported annual household incomes be-
tween £15,000e£70,000 (average of £45,468); the average house-
hold income for north east England, where the NESR is based, was
£28,600 in 2008 (Ofﬁce for National Statistics, 2011). The seven
interviewees who provided eggs were among the higher earners,
with an average household income of £50,786. Higher earning in-
terviewees were no more convinced they could afford private IVF
because of the uncertainties about the eventual costs.
(b) State funding: The limited availability of National Health
Service (NHS)-funded IVF was raised, unprompted, by every inter-
viewee. They were particularly troubled that NHS funding is usually
not available if one partner already has a child:
‘From an NHS point of view I would have had to go through life
without having somebody really close to me, being little, and seeing
them grow up, because [partner] had two grown up children’
(M24:1169e1205).
Some argued for greater ﬂexibility in accessing NHS funding,
suggesting a reciprocal arrangement: ‘If I was getting NHS help they
could have had my eggs for nothing’ (M20:114e23). One woman
angrily said that people who do not approve of the NESR should,
‘set up some scheme where people can get funding, other than
having to wait on the NHS. then you can have some of my eggs for
research, but if you won’t give me the free treatment then at least
give me reduced fees so you can have the eggs’ (M03:1598e1646).
The positioning of NHS-funded cycles in relation to the NESR
was clear: ‘I would prefer the NHS waiting list was not so long [as]
that would be my ﬁrst option and I always wanted [the NESR] to be
a last option’ (M17:937e71). This was echoed by others whose
preference would be to have NHS treatment and not have to
consider giving up eggs.
U.K. national guidelines recommend that IVF patients who meet
local criteria (which vary but often have stipulations about age,
marital status, pre-existing children) should be allowed three cy-
cles of NHS-funded IVF (National Institute of Clinical Excellence,
2004). A recent study shows that that level of provision would
place the UK amongst the lowest providers of state-funded IVF in
Europe (Photopoulos, 2012); approximately 75% of health regions
in England and Wales do not provide even this (All Party
Parliamentary Group on Infertility, 2011). Extensive lobbying in
the north east of England, including by the NFC, led to the ﬁve local
NHS funders implementing the national guidelines. This might
have reduced the number of egg providers for the NESR; their
target was 80, but they recruited 42 (Choudhary et al., 2012).
(c) ‘Money isn’t everything’:Given the cost of private treatment
and the anticipated difﬁculties accessing NHS-funded treatment,
the NESR discount was clearly important. However, interviewees
were cautious in allowing it to determine their actions. It was: ‘not
the be all and end all, but. it is a consideration’ (M19:768e95).
‘Money isn’t everything, success is everything. whilst you’ve got to
take ﬁnances into account you. don’t want to limit any chance of
success’ (M01:776e92). A couple who withdrew said,‘.we started out thinking “ﬁnancially this is a great idea”, morally
we agreed with it .[but] when we didn’t have that many eggs.
we felt, “we don’t care about the money, we should keep all of these
eggs.”’ (M10:863e96).
Signiﬁcantly, although ‘egg sharing for treatment’ (EST) for
other couples would have given them almost free treatment, all but
two interviewees rejected this:
‘ it would be too hard. to even contemplate that somebody else
was having a child from an egg that I had produced, if I was never
going to be able to. But the egg sharing for research, there weren’t
any doubts about that’ (M03:346e410).
Interviewees judged the discount as a proportion of the total
cost of private treatment and therefore in terms of the extra cycles
they would be able to afford:
‘If they said, “Well, you can have it for 25%”, then that’s four chances
and that’s the way we were looking at it, rather than £3000 or
£1500.’(M10:1418e61)
In discussions about whether theywould give eggs for no return
at all, interviewees said they would, if: there were eggs that were
no good for their treatment; there were eggs that they (rather than
anyone else: Scott, Williams, Ehrich, & Farsides, 2012) deemed
‘surplus’ to their needs; they had had a baby; they had decided to
end treatment. Until such circumstances arose they could not give
them for free as, ‘I’ve still got that tiny bit of hope so I need whatever’s
there!’ (M21:1031e48).
The data so far suggest that volunteering for the NESR occurs in
the absence of interviewees’ preferred options of having greater
access to NHS-funded treatment or being able to afford private fees,
and therefore, in both cases, of being able to retain all their eggs.
Interviewees approached the NESR as a scheme throughwhich they
could access cheaper treatments, as a consequence of which they
would give half their eggs to research, rather than as a scheme
persuading them to give up their eggs (even though they were clear
that it existed to acquire eggs for research). This is an important
distinction, as it indicates that volunteers approached theNESRwith
their own goals, rather than merely responding to external in-
ducements. This is further evidenced by the view that cheaper
treatment is not the ‘be all and end all’; having a baby is what really
matters. Nonetheless, the discussion about giving eggs ‘for free’ re-
veals the circumstances in which they would prefer to provide eggs.
Juggling further uncertainties
While reduced fees and the loss of fresh eggs are the two aspects
of the NESR that have attracted most debate, for interviewees there
was a complex array of other biographical, emotional and practical
considerations that also had to be taken into account, and some-
times offset against each other, in making the decision to volunteer.
Each consideration was rife with uncertainty; together they
constituted the entangled backdrop to interviewees’ approaches to
the NESR.
These wider uncertainties included: the beneﬁts of accessing
more treatment against the additional stresses of enduring more
cycles; whether participating in the NESR might result in fewer
embryos to freeze; comparing the chances of success from fresh
embryos from extra treatment to the chances of success from
frozen embryos that they might have had; whether, particularly for
older women, the NESR would mean they could have more treat-
ment, more quickly, than spending precious, ageing, time saving
up; the fear that the NESR might not last for long so they would
have lost an opportunity for cheaper treatment; whether it was
better to volunteer for the NESR or go to other clinics which might
claim better success rates.
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uncertainties as interviewees were pulled in different directions at
once:
‘I’m not normally a gambling person but you’ve got to take that
risk. you start with nothing; hopefully you’ll end up with some-
thing but you might end up with nothing. but you could have a
whole batch of eggs that are all a bad batch [anyway]. So I think
you would take that chance [with the NESR]. and if your ﬁrst
[cycle] doesn’t work at least you’ve got that second attempt
rather than sitting. in the depths of depression worrying about
where you’re going to get your next £2000e3000 from’
(M28:1060e1152).
This interviewee later said, ‘It is [complicated] when you start
thinking about it. [that’s] probably why I only think about it in bits!’
(M28:1657e94). However, it was not easy for volunteers to sepa-
rate out the different elements of ‘IVF þ NESR’, because of all the
unknowns:
‘She said “if you’re producing this many [eggs] there should be no
reason why you wouldn’t do [so] next time”, but you never know.
And.however many [embryos] you freeze, they’re less successful
for implantation. sowe thought, “rather than paying to have them
frozen, we may as well go through the next treatment half
price!”(laughs). you have to laugh about it because you’d cry if
you didn’t.I think [the NESR] was only [available] for a year but
because Iwould have still been under 35, if the NHS one hadn’t come
up, we probably would have done [NESR] again because I would
have still fulﬁlled the criteria with my age.’ (M05:664e711).
Another said: ‘It’s lots of things going on.’ (M10:782e856). This
constant juggling of unknowns led some to reconsider participa-
tion. Two interviewees whowithdrew said of the NESR: ‘it’s not two
for the price of one. because it’s double the emotional cost’
(M10:1544e62); and, ‘The [NESR] did alleviate some ﬁnancial
pressure of not having to ﬁnd the full three thousand pounds but it
doesn’t take away the emotional pressure, the physical pressure’
(M11:1014e44).
For others though:
‘I think [the NESR] would be a last option. I would still worry that it
didn’t give us as good a chance. But if it was an option where it
was to do with time and obviously ﬁnancial, then it’s a last hope
really.’ (M23:688e733).
Therefore, a representation of the NESR as a relatively simple,
linear, relationship between the paucity of state funding, the need
for private IVF, the offer of reduced fees and the consequent deci-
sion to provide eggs (Braun & Schultz, 2012:9) is not an adequate
depiction of volunteers’ experiences. Rather, interviewees juggled
numerous uncertain considerations, which all had to be judged
simultaneously, in relation to each other. Since it is never clear just
which factor will be the key to success, all the ‘balls’ have to be kept
in contention. Given that interviewees likened IVF to a roll-
ercoaster, ‘IVF þ NESR’ can be likened to trying to juggle on a
rollercoaster.
Did the gains outweigh the losses? Interviewees’ evaluations of the
NESR
Deciding to volunteer for the NESR involved a complex navi-
gation throughmultiple uncertainties. Having decided to volunteer,
interviewees had mixed experiences: 15 did not progress beyond
the initial stages of completing a questionnaire to determine suit-
ability while ten others were accepted; three then withdrew and
seven went on to provide eggs. There is insufﬁcient space to detail
those subsequent experiences here, but it is useful to present a briefindication of how interviewees regarded the NESR, at the time of
interview.
Overwhelmingly, interviewees’ assessment of volunteering for
the NESR, whatever their eventual pathway, was, ‘I would do it
again, deﬁnitely. No regrets at all’ (M06:1488e98). As detailed
elsewhere (Haimes et al., 2012) they liked that: they had to initiate
participation rather than be asked by clinicians; there was no direct
or indirect pressure to participate; they had time to consider their
decision; they felt well informed; they were gaining the chance of
more treatment; they could change their minds up to egg collec-
tion; the NESR was part of IVF treatment so nothing extra was
involved, and they were helping research.
All those who provided eggs endorsed these evaluations. Of the
three interviewees who withdrew, one did so because she had the
opportunity of an NHS-funded cycle which was successful; she was
considering volunteering again, since she was not eligible for NHS
funding now she had a baby. Another conceived naturally while
waiting for her NESR cycle. The third changed her mind when she
did not have as many eggs as she had hoped. The decision to
withdraw, amongst this cohort at least, did not arise out of com-
plaints about the scheme. In fact, two of these women said, ‘nowwe
know more what it’s about and how we’re going to feel, we’re going to
try egg sharing again and see it through this time.’ (M10:1165e79)
and ‘I think it [NESR] was a great opportunity. to have that choice
was fantastic’ (M11:1300e1318). A frequent response from those
who did not progress beyond the early stages was that they had no
regrets volunteering. When asked whether the NESR raised the
hopes of patients, only to dash themwhen they were not accepted,
one replied: ‘Any hope is better than no hope’ (M15:1708e65), a view
echoed by others: ‘the whole process [of IVF] is disappointments and
getting your hopes up. I would ask them again, if I could (laughing)!
Take any chance you can get!’ (M21:1384e1402).
Thus the NESR received overwhelming endorsements, even
from those whowithdrew or were unable to participate. It could be
argued that the NESR takes advantage of the patients’ ﬁnancial
difﬁculties but this was not a view expressed by the interviewees
themselves. Rather, they regarded the very existence of the NESR as
a gain. While ‘IVF þ NESR’ brings its own challenges, it is, none-
theless, ‘IVFþ’, it is another option.
Discussion
Recently, the HFEA approved compensation of up to £750, for
expenses and loss of earnings, to anyone providing gametes for
treatment or research (HFEA, 2012b) and the Nufﬁeld Council on
Bioethics recommended a pilot scheme be conducted to assess the
effects of offering ﬁnancial compensation to non-IVF egg providers
(NCoB, 2011:209e210). How best to organise the provision of
gametes for research, including for the expanding ﬁeld of mito-
chondrial research (NCoB, 2012), is clearly still open to debate.
This study shows the importance to these debates of hearing
from those volunteering to provide eggs. The IVF interviewees
frame volunteering for the NESR in terms of the challenge of how to
have a baby and therefore how to access sufﬁcient treatment to
facilitate this. In partial answer to our central research question,
these interviews suggest that volunteering for the NESR does entail
some costs since providing fresh eggs for research is not an easy
solution to the problem of accessing treatment. IVF is a roll-
ercoaster, with sudden emotional, ﬁnancial, physical highs and
lows; the NESR then involves trying to juggle a wide range of other
uncertainties of possible gains and losses while on that roll-
ercoaster. It has been argued that IVF patients should not be con-
fronted by these quandaries ‘at a time of particular vulnerability’
(Waldby & Carroll, 2012:525). That view would derive some sup-
port from the literature questioning the acquisition for research of
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2010; Haimes & Taylor, 2011; Scott et al., 2012), even if one ac-
knowledges the crucial, contextualised, differences between eggs
and embryos. However, these interviewees preferred to have the
option of the NESR, than not, and, rather than buckle under these
challenges, they decide to volunteer (having already, it should be
noted, decided to continue with IVF). Through that decision they
appear to gain both hope and some control over their circum-
stances. Given the not uncommon portrayal of IVF patients as
desperate victims of their infertility, it is important to recognise
that uncertainty can bemanagedwith skill, patience, ‘creativity and
critical agency’ (McLaughlin & Goodley, 2008:331).
While it is important not to overstate the degree of control that
any IVF patients have over their circumstances (Spar, 2006) it is
nonetheless useful to understand how interviewees managed these
uncertainties. Gross (2012:434) reminds us of Simmel’s suggestion
that uncertainty (or ‘nonknowledge’) is a feature of the ‘technicized
society’; it becomes incorporated into everyday life, where ‘the
right strategy cannot be to do nothing or to wait until certain
knowledge is available’. Gross argues that it is the acknowledge-
ment of the role that ‘nonknowledge’ plays in everyday life, rather
than complex analyses of ‘risk’, that leads to a better understanding
of everyday actions. Few interviewees (who are very experienced at
living with uncertainty) engaged in detailed calculations of risk;
most focused instead on their hope (itself a form of uncertainty:
Eliot & Olver, 2007) that extra treatment will increase the chances
of pregnancy. Some reassurance that that hope is not misplaced
comes from recent data from the NFC, not available at the time of
interviews, indicating that the ‘live birth rate per treatment star-
ted’, for NESR egg providers, was 37.25% and 29.4% for matched
comparators (Choudhary et al., 2012). However, the analogy of
trying to juggle on a rollercoaster supports Roberts and Throsby’s
(2008) questioning of the claim that the NESR is a ‘winewin’ for
both volunteers and researchers, exposing this as a gloss on vol-
unteers’ actual experiences.
Reference to interviewees’ skills and resilience is not intended
to underplay the fact that interviewees did not volunteer in cir-
cumstances of their choosing, when already in the position of
trying for a baby in circumstances not of their choosing. Volun-
teering occurs in a context where private IVF fees are too high to
manage easily, or at all, and where there is insufﬁcient NHS-funded
treatment; this supports Braun and Schultz’s (2012:9) assertion
that the attractiveness of ESR schemes will be higher where there
is less state funding for IVF. It also lends weight to those querying
high private fees in the UK and the inadequate implementation of
national guidelines for NHS-funded IVF (Winston, 2011). If both
these were improved, patients might then be in a position to
provide eggs to research under less ambivalent (Brown, 2012:13)
circumstances, in which the role of ‘choice’ becomes clearer. In the
meantime, and in (an admittedly partial) response to the norma-
tive question of whether payments should be offered to women
providing eggs, it is important to reiterate (Haimes et al., 2012) that
the interviewees’ positive endorsements of the NESR are clearly
related to the speciﬁc socio-economic landscape of UK IVF provi-
sion and should not therefore be taken as a simple mandate to
extend IVF ‘egg sharing’ schemes worldwide. Nor should volun-
teers’ endorsements be used to justify offering payments to
encourage egg provision from ‘non-IVF’ women, who occupy a
completely different social position in relation to possible gains,
losses and uncertainties; their perspectives require their own
detailed investigations.
Our study also reveals the ‘thin’ understandings in the bioethics
literature of how potential egg providers manage the concerns
raised in that literature. By attending instead to the Geertzian ‘thick’
descriptions revealed by the inter-subjective particulars ofinterviewees’ everyday lives (Haimes & Williams, 2007), it is
possible to see how those bioethical issues are shaped by the IVF
context. For example, on the question of informed consent, we have
seen that interviewees invoked their previous experience of IVF
(being one of the few certainties in IVF) to explain to themselves
what it was they were volunteering to do. One could argue that
their abilities to act autonomously, and to give better informed
consent, would be compromised less by the offer of reduced fees
and more by the lack of previous treatment (Carroll & Waldby,
2012; Haimes & Taylor, 2009). As Plows (2011:51) argues, we
need to consider the ‘broader political and social background
against which informed consent in a speciﬁc context is given by a
speciﬁc woman’. Our study provides insights into both the broader
background and the speciﬁc context of the NESR; further in depth
studies of egg acquisition practices elsewhere need to be conducted
to understand how those backgrounds and contexts shape volun-
teers’ autonomy.
While the discount was clearly important in the decision to
volunteer for the NESR, volunteers were cautious about providing
eggs if they felt it would seriously compromise their chances of
pregnancy. Also most did not volunteer for EST, even though that
would give them almost free treatment. Therefore, reduced fees
appear not to act as undue inducements persuading volunteers to
act against their own interests (Hyun, 2006:630). This supports
(Sandel’s 2012:91) assessment that ﬁnancial incentives are not
inherently degrading of core values but vary ‘from case to case’, as
does the ‘moral importance of the attitudes and norms that money
may erode’. The interest in beneﬁtting from reduced fees also
suggests that NESR volunteers are not succumbing to appeals to
‘gendered altruism’ (Plows, 2011:51) and thinking they should ‘gift’
their eggs. Rather than asking whether potential egg providers are
motivated by ‘compensation’ or ‘altruism’ (Egli et al., 2011), our
research suggests these terms are not mutually exclusive. In-
terviewees would not ‘give their eggs away’ while pursuing their
goal of a baby, but expressed strong values of future altruism for
when that goal had been achieved or abandoned. Volunteers are
not altruistic, or non-altruistic, by ‘nature’; rather, as the NCoB
recognised, their actions are shaped by speciﬁc biographical, social
and economic contexts (NCoB, 2011:140).
Discussions about payments tend to lead to discussions about
commodiﬁcation. This study suggests that, rather than being ‘paid
to share’ (Roberts & Throsby, 2008) interviewees are exchanging
eggs for treatment; the NESRmightmore appropriately be called an
‘egg exchange’ scheme (Haimes et al., 2012). Volunteers are
potentially exploiting both the ‘use value’ and the ‘exchange value’
of their eggs (Brown, 2012:2e3); since they cannot access IVF on
their preferred terms they can at least use their eggs to get the
treatment they want. While this lends weight to the view that the
NESR encourages the ‘commodiﬁcation’ of human eggs (a contested
term: Almeling (2011:3e21)) it could also be argued that such
concerns hold less sway in the IVF context. IVF requires a frag-
mentation of bodies and the ‘entiﬁcation’ of body parts which
‘become detached.from human bodies. [and] reappear
as.usable entities.that are disposable and available for choice’
(Lie, 2012:1e5). IVF involves calculations of how different bodily
fragments (e.g. sperm, follicles, eggs, embryos) contribute to a
successful outcome (witness Choudhary et al., 2012). As we have
seen from the interviews, IVF also involves calculations (partly
based on the presence and quantities of those fragments) of the
necessity for, and affordability of, further cycles. That is, routine IVF
entails an entanglement of treatment, money, body parts and ba-
bies, but is rarely regarded as commodifying the human body. The
interviews indicate ways in which NESR volunteers can beneﬁt
from these dual processes of entiﬁcation and exchange, rather than
be subjected to them. Equally, the interviews indicate that
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devaluing of body parts. Eggs are both important and exchange-
able; the one does not preclude the other.
Therefore, this study is a resource for the further exploration of
the intertwining of the ‘descriptive’ and the ‘normative’, the moral
and the social. Drawing on the work of Kant, Weber, Wittgenstein,
Louch and others, we have argued elsewhere (Haimes & Williams,
2007:470e472) that these entanglements provide opportunities for
collaborations between sociology and bioethics. Developments in
bioethics over the last ten years suggest a similar interest in these
opportunities (Molewijk and Frith, 2009).
This study also adds to the growing body of social science ana-
lyses (many cited here) of the social practices of provision, acqui-
sition and uses of human reproductive tissue in research. Given the
focus in this paper on presenting new data from the perspectives of
women directly involved, there is insufﬁcient space to detail the
many wider connections that can also be made between this study
and those of others in the global markets for other human tissues.
Nonetheless, one very clear connection is the usefulness of an
analysis of tissue providers’ perspectives which enhance un-
derstandings of theways inwhich they contribute to the global bio-
economy, not least by turning attention towards the labourer, and
her labour, rather than simply focussing on the products of her
labour (Brown, 2012: 13). Such an approach can be usefully com-
bined with those in other ﬁelds, such as Almeling’s (2011) elegant
analysis of the markets for, and ‘donors’ experiences of providing,
gametes for treatment, to enlighten the ways in which situated
speciﬁcities combine with socio-economic and ethical structures to
facilitate, regulate or inhibit such tissue transactions.
Our study has shown that the NESR was welcomed, and
managed, by IVF patients because of its position within the UK IVF
bio-economy. It tells us as much about IVF, and its promises and
problems, as it does about the uncertainties of volunteering for egg
provision. In so doing, it alerts us to avoid treating reproductive
transactions in social and bioethical isolation and instead to trace
the threads of those transactions across the many different social
domains in which they are embedded.Acknowledgements
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